Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Pharmaids Pharmaceuticals Limited

Market Cap 976M 10.27M 8.87M 8.17M 7.65M 14.33M 14.56M 96.48M 37.62M 475M 38.53M 37.71M 1.64B P/E Ratio 2024
-14.8x
P/E Ratio 2025 -22.5x
Enterprise Value 1.34B 14.14M 12.21M 11.26M 10.54M 19.74M 20.05M 133M 51.82M 654M 53.07M 51.94M 2.27B EV / Sales 2024
12,382,225x
EV / Sales 2025 14,298,457x
Free-Float
25.74%
Yield 2024 *
-
Yield 2025 -
05-29 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
02-12 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
01-05 Pharmaids Pharmaceuticals Limited Announces Completion of Term of Mopperthy Sudheer as Independent Director and Member of the Audit Committee and Nomination & Remuneration Committee, Effective January 5, 2026 CI
01-02 Pharmaids Pharmaceuticals Limited Appoints Dr. Yogananda Moolemath as Independent Director, Effective January 1, 2026 CI
11-28 Pharmaids Pharmaceuticals appoints P N Vijay as chairman effective December 5, 2025 RE
11-28 Pharmaids Pharmaceuticals Limited Announces Board and Committee Changes CI
11-11 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-17 Sourabh Hadimani completed the acquisition of 66.50% stake in Anugraha Chemicals P. Ltd. from Pharmaids Pharmaceuticals Limited. CI
25-08-17 Shankarappa Nagaraja Vinaya Babu completed the acquisition of 7.68% stake in Pharmaids Pharmaceuticals Limited for approximately INR 170 million. CI
25-08-07 Pharmaids Pharmaceuticals Limited Announces Executive Changes, Effective August 7, 2025 CI
25-08-07 Pharmaids Pharmaceuticals Limited Announces Resignation of S Prasad as the Chief Executive Officer Effective August 07, 2025 CI
25-08-07 Pharmaids Pharmaceuticals CEO S Prasad resigns RE
25-08-07 Pharmaids Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
1 day+1.54%
1 week+4.70%
Current month-4.55%
1 month-7.12%
3 months-18.63%
6 months-42.14%
Current year-39.24%
1 week 26
Extreme 26
30.9
1 month 25.6
Extreme 25.6
33.8
Current year 25.6
Extreme 25.6
50.9
1 year 25.6
Extreme 25.6
70
3 years 25.6
Extreme 25.6
87.46
5 years 10.17
Extreme 10.17
87.46
10 years 2.15
Extreme 2.15
87.46
Manager TitleAgeSince
Director of Finance/CFO - 2022-10-12
Chief Tech/Sci/R&D Officer - 2025-08-06
Compliance Officer - 2024-08-13
Director TitleAgeSince
Director/Board Member - 2022-07-08
Director/Board Member - -
Chairman 74 2025-12-04
Change 5-day change 1-year change 3-year change Capi.($)
+1.54%+4.70%-50.67%-3.47% 10.5M
-2.41%+0.69%+40.12%+154.01% 1,035B
+1.07%+5.57%+55.14%+50.53% 574B
+1.32%+1.24%+18.92%+64.81% 397B
+0.77%+0.77%+21.19%+15.95% 324B
-0.85%-0.68%+23.44%+14.94% 281B
+0.44%+5.39%+25.86%+35.39% 278B
+1.66%+1.20%-44.41%-47.37% 193B
+0.32%+2.78%+21.72%+62.37% 191B
-0.22%-2.78%+14.90%+60.77% 156B
Average +0.02%+1.82%+12.62%+40.79% 342.99B
Weighted average by Cap. -0.74%+2.39%+28.93%+71.62%

Financials

2024 2025
Net sales 151.12 1.59 1.37 1.27 1.18 2.22 2.25 14.94 5.83 73.56 5.97 5.84 254.69 195.14 2.05 1.77 1.63 1.53 2.87 2.91 19.29 7.52 94.98 7.7 7.54 328.87
Net income -79.68M -838K -724K -667K -625K -1.17M -1.19M -7.88M -3.07M -38.78M -3.15M -3.08M -134M -108M -1.13M -979K -902K -845K -1.58M -1.61M -10.65M -4.15M -52.45M -4.26M -4.16M -182M
Net Debt 37.29M 392K 339K 312K 292K 548K 556K 3.69M 1.44M 18.15M 1.47M 1.44M 62.84M 368M 3.87M 3.35M 3.08M 2.89M 5.41M 5.49M 36.41M 14.2M 179M 14.54M 14.23M 621M
Logo Pharmaids Pharmaceuticals Limited
Pharmaids Pharmaceuticals Limited is an India-based suppliers of a range of specialty chemicals, skin care, hospital care and generic products in the areas of orthopedic, neuro and gastro, and other. The Company is engaged in the business of trading and manufacturing of generics, bulk drugs, and intermediaries, and other. The Company operates through Bulk Drugs and Intermediates segment. Its specialty chemicals products include Retinol, DL Alpha Tocopherol, D Pantothenate, Cyanocobalamin, Pyridoxine Hcl, Thiamine, Nicotinic Acid, Water Sol. Vitamin E, Coenzyme Q10 and D-Biotin. Its skin care products include Best care hands, Hands Sanitizer, Moisturizing Cream, Skinsure Plus, SkinSure Ultra, Alcohol Gel and Barrier Cream. Its hospital care products include Xepi Rub M, Facein Spray, Sod Hypochlorite, Sanmedin, Strumen G, Strumen TRIACID, Facein Eco, Facein Power 256, Facein Spray, Sod Hypochlorite, Wipes and PPE. Its generic products include Linzomust, Benfoshine, Duojoint, and other.
Employees
28
Date Price Change Volume
26-06-12 28.96 +1.54% 3,206
26-06-11 28.52 +1.82% 4,865
26-06-10 28.01 +0.18% 11,123
26-06-09 27.96 +3.02% 24,870
26-06-08 27.14 -1.74% 15,806
  1. Stock Market
  2. Stocks
  3. 524572 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!